Benitec Biopharma Ltd ADR (BNTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2015 | 06-2014 | 06-2013 | 06-2007 | 06-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,637 | -6,464 | -3,583 | N/A | N/A |
| Depreciation Amortization | 81 | 12 | 31 | N/A | N/A |
| Accounts receivable | -1 | -15 | 23 | N/A | N/A |
| Accounts payable and accrued liabilities | 554 | 255 | 206 | N/A | N/A |
| Other Working Capital | 656 | -2,395 | 260 | N/A | N/A |
| Other Operating Activity | 231 | 95 | 256 | 0 | 0 |
| Operating Cash Flow | $-8,115 | $-8,513 | $-2,807 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -423 | -30 | -10 | N/A | N/A |
| Net Acquisitions | N/A | N/A | 148 | N/A | N/A |
| Investing Cash Flow | $-423 | $-30 | $137 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 322 | 35,883 | 1,117 | N/A | N/A |
| Other Financing Activity | -279 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $44 | $35,883 | $1,117 | $N/A | $N/A |
| Exchange Rate Effect | 480 | -1 | 24 | N/A | N/A |
| Beginning Cash Position | 26,257 | 1,458 | 3,160 | N/A | N/A |
| End Cash Position | 18,242 | 28,797 | 1,631 | N/A | N/A |
| Net Cash Flow | $-8,015 | $27,341 | $-1,529 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,115 | -8,513 | -2,807 | N/A | N/A |
| Capital Expenditure | -423 | -30 | -10 | N/A | N/A |
| Free Cash Flow | -8,538 | -8,543 | -2,817 | 0 | 0 |